TY - JOUR
T1 - WHO global research priorities for antimicrobial resistance in human health
AU - WHO Research Agenda for AMR in Human Health Collaborators
AU - Bertagnolio, Silvia
AU - Dobreva, Zlatina
AU - Centner, Chad M.
AU - Olaru, Ioana Diana
AU - Donà, Daniele
AU - Burzo, Stefano
AU - Huttner, Benedikt D.
AU - Chaillon, Antoine
AU - Gebreselassie, Nebiat
AU - Wi, Teodora
AU - Hasso-Agopsowicz, Mateusz
AU - Allegranzi, Benedetta
AU - Sati, Hatim
AU - Ivanovska, Verica
AU - Kothari, Kavita U.
AU - Balkhy, Hanan H.
AU - Cassini, Alessandro
AU - Hamers, Raph L.
AU - Weezenbeek, Kitty Van
AU - Aanensen, David
AU - Alanio, Alexandre
AU - Alastruey-Izquierdo, Ana
AU - Alemayehu, Tinsae
AU - Al-Hasan, Majdi
AU - Allegaert, Karel
AU - Al-Maani, Amal Saif
AU - Al-Salman, Jameela
AU - Alshukairi, Abeer Nizar
AU - Amir, Afreenish
AU - Applegate, Tanya
AU - Araj, George F.
AU - Villalobos, Marlen Arce
AU - Årdal, Christine
AU - Ashiru-Oredope, Diane
AU - Ashley, Elizabeth A.
AU - Babin, François Xavier
AU - Bachmann, Laura H.
AU - Bachmann, Till
AU - Baker, Kate Susan
AU - Balasegaram, Manica
AU - Bamford, Colleen
AU - Baquero, Fernando
AU - Barcelona, Laura Isabel
AU - Bassat, Quique
AU - Bassetti, Matteo
AU - Basu, Sulagna
AU - Beardsley, Justin
AU - Vásquez, Grey Benoit
AU - Berkley, James A.
AU - Schwaber, Mitchell J.
N1 - Publisher Copyright:
© 2024
PY - 2024
Y1 - 2024
N2 - The WHO research agenda for antimicrobial resistance (AMR) in human health has identified 40 research priorities to be addressed by the year 2030. These priorities focus on bacterial and fungal pathogens of crucial importance in addressing AMR, including drug-resistant pathogens causing tuberculosis. These research priorities encompass the entire people-centred journey, covering prevention, diagnosis, and treatment of antimicrobial-resistant infections, in addition to addressing the overarching knowledge gaps in AMR epidemiology, burden and drivers, policies and regulations, and awareness and education. The research priorities were identified through a multistage process, starting with a comprehensive scoping review of knowledge gaps, with expert inputs gathered through a survey and open call. The priority setting involved a rigorous modified Child Health and Nutrition Research Initiative approach, ensuring global representation and applicability of the findings. The ultimate goal of this research agenda is to encourage research and investment in the generation of evidence to better understand AMR dynamics and facilitate policy translation for reducing the burden and consequences of AMR.
AB - The WHO research agenda for antimicrobial resistance (AMR) in human health has identified 40 research priorities to be addressed by the year 2030. These priorities focus on bacterial and fungal pathogens of crucial importance in addressing AMR, including drug-resistant pathogens causing tuberculosis. These research priorities encompass the entire people-centred journey, covering prevention, diagnosis, and treatment of antimicrobial-resistant infections, in addition to addressing the overarching knowledge gaps in AMR epidemiology, burden and drivers, policies and regulations, and awareness and education. The research priorities were identified through a multistage process, starting with a comprehensive scoping review of knowledge gaps, with expert inputs gathered through a survey and open call. The priority setting involved a rigorous modified Child Health and Nutrition Research Initiative approach, ensuring global representation and applicability of the findings. The ultimate goal of this research agenda is to encourage research and investment in the generation of evidence to better understand AMR dynamics and facilitate policy translation for reducing the burden and consequences of AMR.
UR - http://www.scopus.com/inward/record.url?scp=85201120507&partnerID=8YFLogxK
U2 - 10.1016/S2666-5247(24)00134-4
DO - 10.1016/S2666-5247(24)00134-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:85201120507
SN - 2666-5247
JO - The Lancet Microbe
JF - The Lancet Microbe
M1 - 100902
ER -